.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
Novartis
Baxter
Cantor Fitzgerald
Johnson and Johnson
Queensland Health
Cerilliant
Citi

Generated: September 26, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Altana

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
1664III3/2/1971ALTANA INCMANUF FACILITIES, PERSONNEL AND MANUF. CONTROLS
4382III12/7/1981ALTANA LOMBERG CHEMISCHE FABRIKURAPIDIL DRUG SUBSTANCE
4563III6/18/1982PHARMADERM DIV ALTANA INCURAPIDIL AMPULES AS PRODUCED IN THE HICKSVILLE, NY FACILITY
6081III9/26/1985ALTANA LOMBERG CHEMISCHE FABRIKBUDIPINE-HYDROCHLORIDE
6818III2/11/1987ALTANA LOMBERG CHEMISCHE FABRIKTHEOPHYLLINE SUSTAINED RELEASE CAPSULES (BY-158)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Chubb
Colorcon
UBS
Cerilliant
McKesson
QuintilesIMS
Teva
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot